InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,266.95
(
0.28%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: BTH post# 8199

Thursday, 05/19/2011 9:26:06 AM

Thursday, May 19, 2011 9:26:06 AM

Post# of 80490
Well, the rida endometrial trial showed over 100% improvement in pts who achieved stable disease vs the control arm. The benefit has to be coming from somewhere, lol. Furthermore, the CBR that the majority of the pts in the everolimus trial was from....wait for it....achieving stable disease.

Also, your post to the contrary, rida appears to be far more tolerable in this setting than everolimus.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up